The challenges of maintaining momentum in CF drug development and approval - Commentary

J Cyst Fibros. 2017 Mar;16(2):170-171. doi: 10.1016/j.jcf.2017.01.014. Epub 2017 Feb 5.
No abstract available

MeSH terms

  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis / metabolism
  • Cystic Fibrosis / physiopathology
  • Cystic Fibrosis Transmembrane Conductance Regulator / physiology
  • Drug Approval*
  • Drug Development*
  • Drug Discovery* / methods
  • Drug Discovery* / trends
  • Humans
  • Medication Therapy Management / trends*
  • Molecular Targeted Therapy / methods
  • Patient Care Management* / methods
  • Patient Care Management* / trends
  • Treatment Outcome

Substances

  • CFTR protein, human
  • Cystic Fibrosis Transmembrane Conductance Regulator